aluates Reports

$ 0.0

Automative

Global Oncolytic Virus Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-7V9256

Global Oncolytic Virus Market Outlook 2022

BUY CHAPTERS

Global Oncolytic Virus Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-7V9256

Report

June 2025

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Shanghai Sunway Biotech

Oncolytic Virus Market Size

In 2024, the global market size of Oncolytic Virus was estimated to be worth US$ 19.4 million and is forecast to reach approximately US$ 30.5 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.

Oncolytic Virus Market

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus.

The Oncolytic Virus market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncolytic Virus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncolytic Virus companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Oncolytic Virus Market Report

Report Metric	Details
Report Name	Oncolytic Virus Market
Forecasted market size in 2031	approximately US$ 30.5 million
CAGR	6.8%
Forecasted years	2025 - 2031
Segment by Type	Imlygic Oncorine Others
Segment by Application	Melanoma Other Cancers
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Shanghai Sunway Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Oncolytic Virus in global and regional level.
Chapter 3: Detailed analysis of Oncolytic Virus company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncolytic Virus revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Oncolytic Virus Market size in 2031?

Ans: The Oncolytic Virus Market size in 2031 will be approximately US$ 30.5 million.

Who are the main players in the Oncolytic Virus Market report?

Ans: The main players in the Oncolytic Virus Market are Amgen, Shanghai Sunway Biotech

What are the Application segmentation covered in the Oncolytic Virus Market report?

Ans: The Applications covered in the Oncolytic Virus Market report are Melanoma, Other Cancers

What are the Type segmentation covered in the Oncolytic Virus Market report?

Ans: The Types covered in the Oncolytic Virus Market report are Imlygic, Oncorine, Others

1 Study Coverage

1.1 Oncolytic Virus Product Introduction

1.2 Market by Type

1.2.1 Global Oncolytic Virus Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Imlygic

1.2.3 Oncorine

1.2.4 Others

1.3 Market by Application

1.3.1 Global Oncolytic Virus Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Melanoma

1.3.3 Other Cancers

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Oncolytic Virus Market Size Estimates and Forecasts

2.2 Oncolytic Virus Market Size by Region: 2024 Versus 2031

2.2.1 Global Oncolytic Virus Revenue by Region: 2020-2025

2.2.2 Global Oncolytic Virus Revenue Forecast by Region (2026-2031)

2.2.3 Global Oncolytic Virus Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Oncolytic Virus Revenue by Type (2020-2031)

3.1.2 Global Oncolytic Virus Revenue Market Share by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Oncolytic Virus Revenue by Application (2020-2031)

3.2.2 Global Oncolytic Virus Revenue Market Share by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Imlygic of Oncolytic Virus Revenue Market Share by Application

3.3.2 Oncorine of Oncolytic Virus Revenue Market Share by Application

3.3.3 Others of Oncolytic Virus Revenue Market Share by Application

4 Global Oncolytic Virus by Company

4.1 Global Oncolytic Virus Revenue by Company (2020-2025)

4.2 Global Oncolytic Virus Revenue Share by Company (2020-2025)

4.3 Competitive Landscape

4.3.1 Key Oncolytic Virus Companies around the World: Ranking by Revenue

4.3.2 Global Oncolytic Virus Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.3.3 Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.4 Global Oncolytic Virus Companies Headquarters & Product Type

4.4.1 Global Oncolytic Virus Companies Headquarters

4.4.2 Date of International Companies Enter into Oncolytic Virus Market

4.4.3 Global Oncolytic Virus Companies Product & Service

4.4.4 Imlygic Revenue Market Share of Oncolytic Virus by Company

4.5 Global Oncolytic Virus Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Amgen

5.1.1 Amgen Corporation Information

5.1.2 Amgen Description, Business Overview

5.1.3 Amgen Oncolytic Virus Products Offered

5.1.4 Amgen Oncolytic Virus Revenue and Gross Margin (2020-2025)

5.1.5 Amgen Oncolytic Virus Revenue by Product in 2024

5.1.6 Amgen Oncolytic Virus Revenue by Application in 2024

5.1.7 Amgen Oncolytic Virus Revenue by Geographic Area in 2024

5.1.8 Amgen Recent Developments

5.2 Shanghai Sunway Biotech

5.2.1 Shanghai Sunway Biotech Corporation Information

5.2.2 Shanghai Sunway Biotech Description, Business Overview

5.2.3 Shanghai Sunway Biotech Oncolytic Virus Products Offered

5.2.4 Shanghai Sunway Biotech Oncolytic Virus Revenue and Gross Margin (2020-2025)

5.2.5 Shanghai Sunway Biotech Oncolytic Virus Revenue by Product in 2024

5.2.6 Shanghai Sunway Biotech Oncolytic Virus Revenue by Application in 2024

5.2.7 Shanghai Sunway Biotech Oncolytic Virus Revenue by Geographic Area in 2024

5.2.8 Shanghai Sunway Biotech Recent Developments

6 North America

6.1 North America Oncolytic Virus Market Size YoY Growth 2020-2031

6.2 North America Oncolytic Virus Market Facts & Figures by Country (2020-2031)

6.3 North America Oncolytic Virus Revenue by Type (2020-2025)

6.4 North America Oncolytic Virus Revenue by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Oncolytic Virus Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Oncolytic Virus Market Facts & Figures by Region (2020-2031)

7.3 Asia-Pacific Oncolytic Virus Revenue by Type (2020-2025)

7.4 Asia-Pacific Oncolytic Virus Revenue by Application (2020-2025)

8 Europe

8.1 Europe Oncolytic Virus Market Size YoY Growth 2020-2031

8.2 Europe Oncolytic Virus Market Facts & Figures by Country (2020-2031)

8.3 Europe Oncolytic Virus Revenue by Type (2020-2025)

8.4 Europe Oncolytic Virus Revenue by Application (2020-2025)

9 Latin America

9.1 Latin America Oncolytic Virus Market Size YoY Growth 2020-2031

9.2 Latin America Oncolytic Virus Market Facts & Figures by Country (2020-2031)

9.3 Latin America Oncolytic Virus Revenue by Type (2020-2025)

9.4 Latin America Oncolytic Virus Revenue by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Oncolytic Virus Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country (2020-2031)

10.3 Middle East and Africa Oncolytic Virus Revenue by Type (2020-2025)

10.4 Middle East and Africa Oncolytic Virus Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Oncolytic Virus Supply Chain Analysis

11.2 Oncolytic Virus Key Raw Materials and Upstream Suppliers

11.3 Oncolytic Virus Clients Analysis

11.4 Oncolytic Virus Sales Channel and Sales Model Analysis

11.4.1 Oncolytic Virus Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Oncolytic Virus Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Oncolytic Virus Distributors

12 Oncolytic Virus Market Dynamics

12.1 Oncolytic Virus Industry Trends

12.2 Oncolytic Virus Market Drivers

12.3 Oncolytic Virus Market Challenges

12.4 Oncolytic Virus Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Shanghai Sunway Biotech

List of Tables

Table 1. Global Oncolytic Virus Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Oncolytic Virus Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Oncolytic Virus Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Oncolytic Virus Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Oncolytic Virus Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Oncolytic Virus Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Oncolytic Virus Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Oncolytic Virus Revenue by Company (2020-2025) & (US$ Million)

Table 11. Oncolytic Virus Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Oncolytic Virus Players by Revenue (US$ Million) in 2024

Table 13. Global Oncolytic Virus Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Oncolytic Virus by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus as of 2024)

Table 15. Global Oncolytic Virus Companies Headquarters

Table 16. Date of International Companies Enter into Oncolytic Virus Market

Table 17. Global Oncolytic Virus Companies Product & Service

Table 18. Global Oncolytic Virus Mergers & Acquisitions, Expansion Plans

Table 19. Amgen Corporation Information

Table 20. Amgen Description and Business Overview

Table 21. Amgen Oncolytic Virus Product

Table 22. Amgen Oncolytic Virus Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. Amgen Revenue Proportion of Oncolytic Virus by Product in 2024

Table 24. Amgen Revenue Proportion of Oncolytic Virus by Application in 2024

Table 25. Amgen Revenue Proportion of Oncolytic Virus by Geographic Area in 2024

Table 26. Amgen Recent Developments

Table 27. Shanghai Sunway Biotech Corporation Information

Table 28. Shanghai Sunway Biotech Description and Business Overview

Table 29. Shanghai Sunway Biotech Oncolytic Virus Product

Table 30. Shanghai Sunway Biotech Oncolytic Virus Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Shanghai Sunway Biotech Revenue Proportion of Oncolytic Virus by Product in 2024

Table 32. Shanghai Sunway Biotech Revenue Proportion of Oncolytic Virus by Application in 2024

Table 33. Shanghai Sunway Biotech Revenue Proportion of Oncolytic Virus by Geographic Area in 2024

Table 34. Shanghai Sunway Biotech Recent Developments

Table 35. North America Oncolytic Virus Revenue by Country (2020-2025) & (US$ Million)

Table 36. North America Oncolytic Virus Revenue by Country (2026-2031) & (US$ Million)

Table 37. North America Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)

Table 38. North America Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Oncolytic Virus Revenue by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Oncolytic Virus Revenue by Region (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)

Table 43. Europe Oncolytic Virus Revenue by Country (2020-2025) & (US$ Million)

Table 44. Europe Oncolytic Virus Revenue by Country (2026-2031) & (US$ Million)

Table 45. Europe Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)

Table 46. Europe Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)

Table 47. Latin America Oncolytic Virus Revenue by Country (2020-2025) & (US$ Million)

Table 48. Latin America Oncolytic Virus Revenue by Country (2026-2031) & (US$ Million)

Table 49. Latin America Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)

Table 50. Latin America Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)

Table 51. Middle East and Africa Oncolytic Virus Revenue by Country (2020-2025) & (US$ Million)

Table 52. Middle East and Africa Oncolytic Virus Revenue by Country (2026-2031) & (US$ Million)

Table 53. Middle East and Africa Oncolytic Virus Revenue by Type (2020-2025) & (US$ Million)

Table 54. Middle East and Africa Oncolytic Virus Revenue by Application (2020-2025) & (US$ Million)

Table 55. Oncolytic Virus Key Raw Materials, Industry Status and Trend

Table 56. Oncolytic Virus Key Raw Materials and Upstream Suppliers

Table 57. Oncolytic Virus Clients Status and Trend

Table 58. Oncolytic Virus Typical Clients

Table 59. Oncolytic Virus Distributors

Table 60. Oncolytic Virus Market Trends

Table 61. Oncolytic Virus Market Drivers

Table 62. Oncolytic Virus Market Challenges

Table 63. Oncolytic Virus Market Restraints

Table 64. Research Programs/Design for This Report

Table 65. Key Data Information from Secondary Sources

Table 66. Key Data Information from Primary Sources

List of Figures

Figure 1. Oncolytic Virus Product Picture

Figure 2. Global Oncolytic Virus Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Oncolytic Virus Revenue Market Share by Type in 2024 & 2031

Figure 4. Imlygic Product Picture

Figure 5. Oncorine Product Picture

Figure 6. Others Product Picture

Figure 7. Global Oncolytic Virus Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 8. Global Oncolytic Virus Revenue Market Share by Application in 2024 & 2031

Figure 9. Melanoma

Figure 10. Other Cancers

Figure 11. Oncolytic Virus Report Years Considered

Figure 12. Global Oncolytic Virus Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Oncolytic Virus Market Size (2020-2031) & (US$ Million)

Figure 14. Global Oncolytic Virus Market Size Market Share by Region: 2024 Versus 2031

Figure 15. Global Oncolytic Virus Revenue Market Share by Region (2020-2031)

Figure 16. Global Oncolytic Virus Revenue Market Share Forecast by Type (2020-2031)

Figure 17. Global Oncolytic Virus Revenue Market Share Forecast by Application (2020-2031)

Figure 18. Imlygic of Oncolytic Virus Revenue Market Share by Application, 2024 VS 2031

Figure 19. Oncorine of Oncolytic Virus Revenue Market Share by Application, 2024 VS 2031

Figure 20. Others of Oncolytic Virus Revenue Market Share by Application, 2024 VS 2031

Figure 21. Oncolytic Virus Revenue Share by Company (2024)

Figure 22. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Imlygic Revenue Proportion by Company in 2024

Figure 24. Oncorine Revenue Proportion by Company in 2024

Figure 25. Others Revenue Proportion by Company in 2024

Figure 26. North America Oncolytic Virus Revenue 2020-2031 (US$ Million)

Figure 27. North America Oncolytic Virus Revenue Market Share by Type (2020-2025)

Figure 28. North America Oncolytic Virus Revenue Market Share by Application (2020-2025)

Figure 29. Asia-Pacific Oncolytic Virus Revenue 2020-2031 (US$ Million)

Figure 30. Asia-Pacific Oncolytic Virus Revenue Market Share by Region (2020-2031)

Figure 31. Asia-Pacific Oncolytic Virus Revenue Market Share by Type (2020-2025)

Figure 32. Asia-Pacific Oncolytic Virus Revenue Market Share by Application (2020-2025)

Figure 33. Europe Oncolytic Virus Revenue Growth Rate 2020-2031 (US$ Million)

Figure 34. Europe Oncolytic Virus Revenue Market Share by Country (2020-2031)

Figure 35. Europe Oncolytic Virus Revenue Market Share by Type (2020-2025)

Figure 36. Europe Oncolytic Virus Revenue Market Share by Application (2020-2025)

Figure 37. Latin America Oncolytic Virus Revenue Growth Rate 2020-2031 (US$ Million)

Figure 38. Latin America Oncolytic Virus Revenue Market Share by Country (2020-2031)

Figure 39. Latin America Oncolytic Virus Revenue Market Share by Type (2020-2025)

Figure 40. Latin America Oncolytic Virus Revenue Market Share by Application (2020-2025)

Figure 41. Middle East and Africa Oncolytic Virus Revenue Growth Rate 2020-2031 (US$ Million)

Figure 42. Middle East and Africa Oncolytic Virus Revenue Market Share by Country (2020-2031)

Figure 43. Middle East and Africa Oncolytic Virus Revenue Market Share by Type (2020-2025)

Figure 44. Middle East and Africa Oncolytic Virus Revenue Market Share by Application (2020-2025)

Figure 45. Oncolytic Virus Supply Chain (Upstream and Downstream Market)

Figure 46. Global Production Market Share of Oncolytic Virus Raw Materials by Region in 2024

Figure 47. Oncolytic Virus Distribution Channels

Figure 48. Global Oncolytic Virus Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 49. Global Oncolytic Virus Percentage 2020-2031: Online Sales VS Offline Sales

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oncolytic Virus Cancer Immunotherapy Market Insights Forecast to 2030

Global Oncolytic Virus Manufacturing and Development Services Market Research Report 2024

Global Oncolytic Virus Manufacturing Services Market Research Report 2024

Global Oncolytic Viral Drugs Market Research Report 2024

Global Oncolytic Virus Immunotherapy Market Research Report 2024

Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Gene Therapy in Oncology Market Research Report 2024

Global Oncolytic Virus Drug Treatment Market Research Report 2025

Global Gene Therapy For Cancer Market Research Report 2024

Global Viral Vectors Gene Therapy Market Research Report 2025

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Bacteriophages Therapy Service Market Insights Forecast to 2030

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

Global Bacteriophage Market Insights Forecast to 2030

Global Immunotherapeutic Drugs Market Insights Forecast to 2030

Global Therapeutic Cancer Vaccines Market Research Report 2024

Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024

Global Gene Therapies for Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21N6899

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13M6952

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29X7355

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28B293

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Oncolytic Virus Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Published Date: June 2025

Report Code: QYRE-Auto-7V9256

Global Oncolytic Virus Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

FEATURED COMPANIES

Oncolytic Virus Market Size

Oncolytic Virus Market

Report Scope

Scope of Oncolytic Virus Market Report

Chapter Outline

FAQ for this report

What is the Oncolytic Virus Market size in 2031?

Who are the main players in the Oncolytic Virus Market report?

What are the Application segmentation covered in the Oncolytic Virus Market report?

What are the Type segmentation covered in the Oncolytic Virus Market report?

FEATURED COMPANIES

RELATED REPORTS